Abliva
1 known investors
Find your way into Abliva
Sign up to see every warm intro you have to Abliva
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Abliva team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Abliva develops treatments for primary mitochondrial disease, a rare orphan disease caused by impaired cellular energy metabolism in the mitochondria. The company focuses on pharmaceutical research and development to address an unmet medical need where no effective treatments currently exist.
Investors · 1
Hadean Ventureslisted by Hadean VenturesOslo
How we know: Hadean Ventures's portfolio page · funding news · Not right? Tell us
Frequently asked questions
- What does Abliva do?
- Abliva develops treatments for primary mitochondrial disease, a rare orphan disease caused by impaired cellular energy metabolism in the mitochondria. The company focuses on pharmaceutical research and development to address an unmet medical need where no effective treatments currently exist.
- Who are Abliva's investors?
- Abliva's investors include Hadean Ventures.